Target intelligence / Profile preview

Fibroblast growth factor receptor substrate 3 (FRS3)

Target
FRS3
Molecular classification
Adapter protein, Scaffold protein, Cytoplasmic signaling adaptor (Subfamily: FGFR substrate family)
01

Overview

Fibroblast growth factor receptor substrate 3 (FRS3) is an adapter protein localized to the peripheral plasma membrane that serves as a critical link in transducing signals from activated fibroblast growth factor receptors (FGFRs) to intracellular effectors, particularly the MAPK (Mitogen-Activated Protein Kinase) and PI3K/AKT pathways[1][3][6]. Upon FGFR stimulation, FRS3 becomes tyrosine phosphorylated, subsequently recruiting downstream signaling components such as GRB2 and Gab1, and modulating diverse cellular functions including differentiation and proliferation[1][3]. FRS3 is especially important in mediating FGFR1 function during neuronal development and can also participate in signaling from neurotrophin receptors such as NTRK1-3[3]. While it shares structural and functional similarity with FRS2, FRS3 has distinct, context-dependent roles, particularly in the negative regulation of ERK2 activity and in certain cancer types including thyroid and prostate cancer[3][6]. Defects or dysregulation in FRS3-mediated signaling have been implicated in cancer pathogenesis and developmental disorders such as Kallmann syndrome and multiple endocrine neoplasia[1][2][6]. Notes: - FRS3 is considered an adaptor/scaffold protein, not a receptor or enzyme itself; thus, it does not have known drug ligands or approved therapies targeting it directly as of current knowledge[3][6]. - There are closely related paralogs such as FRS2 (also known as SNT-1 or FRS2-alpha)[1][3]. - Contextual data (e.g., kidney, neuronal, or endocrine development) suggest roles in highly regulated developmental pathways and malignancy[1][3][6].

Other names
FRS3FRS2BFRS2-betaFRS2betaSNT-2SNT2FGFR substrate 3FGFR-signaling adaptor SNT2Suc1-associated neurotrophic factor target 2testicular tissue protein Li 71
02

Mechanism of action

Adapter or scaffold for FGFR, transmitting signals to MAPK/ERK and PI3K/AKT pathways; required for FGFR1-mediated signaling; mediates signal transduction from select neurotrophin receptors (e.g., NTRK1, NTRK2, NTRK3)

03

Biological functions

Signal transductionCell differentiationDownstream MAPK and PI3K pathway regulationModulation of ERK2 activityNegative regulation of EGF receptor signalingNeuronal development
04

Disease associations

CancerMultiple endocrine neoplasiaKallmann syndromeThyroid carcinogenesisProstate cancer

Beyond the preview

Go deeper on Fibroblast growth factor receptor substrate 3 (FRS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibroblast growth factor receptor substrate 3 (FRS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call